CENYX BIOTECH

Recently, these nanoparticles are being called "nanozyme" as they mimic the function of intrinsic enzymes while its potency can be miximized due to their huge surface-to-volume ratio. Few companies have focused on clinical applications of nanozymes, although this area of research has been highlighted for more than a decade in academia. Cenyx is the first nanozyme biotech company founded by Korea's experienced research team in a university hospital. Although nanozymes have not yet been developed in the conventional pharmaceutical industry, they would have immeasurable social and economic implications once proven as applicable in humans because of their therapeutic potential... How many people could have predicted that monoclonal antibodies would be the most important therapeutics in the global pharmaceutical and healthcare industries in the late 1990s, when only a few biologics were available?​ The field of nanocatalytic medicine has just begun to sprout up worldwide, and in the midst..

Also known as: Cenyx, Cenyx Biotech Inc.

Primary location: Seoul Korea